// App-Quantinova.ai

8525 : A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801).

Researchers

Presenter

  • Koji Kawaguchi

Principal Investigators

  • Kohei Yokoi

  • Hiroshi Niwa

  • Yasuhisa Ohde

  • Shoichi Mori

  • Sakae Okumura

  • Satoshi Shiono

  • Hiroyuki Ito

  • Motoki Yano

  • Kikuo Shigemitsu

  • Yoshinori Hiramatsu

  • Jiro Okami

  • Hideo Saka

Medical Centers

  • Department of Thoracic Surgery, Nagoya University, Nagoya, Japan

  • Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, Hamamatsu, Japan

  • Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan

  • Department of Thoracic Surgery, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan

  • Department of Thoracic Surgical Oncology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan

  • Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan

  • Division of Thoracic Surgery, Thoracic Oncology, and Pathology, Kanagawa Cancer Center, Yokohama, Japan

  • Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

  • Department of Thoracic Surgery, Ogaki Municipal Hospital, Ogaki, Japan

  • Department of Thoracic Surgery, Toyota Kosei Hospital, Toyota, Japan

  • Department of General Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

  • Nagoya Medical Center, Nagoya, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Vinorelbine

  • Cisplatin

Outcome

  • N/A


Study Design

  • Multicenteric

  • Prospective

Phase

  • II

Study Id's

  • UMIN000001810

Sponsors

  • N/A

Result

  • Final